Compare ULBI & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ULBI | ECOR |
|---|---|---|
| Founded | 1990 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.1M | 85.6M |
| IPO Year | 1995 | 2018 |
| Metric | ULBI | ECOR |
|---|---|---|
| Price | $5.64 | $12.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 32.2K | ★ 77.2K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 13.00 | N/A |
| Revenue | ★ $191,159,000.00 | $32,032,000.00 |
| Revenue This Year | $20.00 | $33.60 |
| Revenue Next Year | N/A | $30.40 |
| P/E Ratio | $0.43 | ★ N/A |
| Revenue Growth | 16.24 | ★ 27.20 |
| 52 Week Low | $4.90 | $4.41 |
| 52 Week High | $8.25 | $12.12 |
| Indicator | ULBI | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 40.36 | 75.39 |
| Support Level | $5.59 | $5.70 |
| Resistance Level | $6.33 | N/A |
| Average True Range (ATR) | 0.24 | 0.66 |
| MACD | -0.03 | 0.24 |
| Stochastic Oscillator | 28.14 | 99.72 |
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company also designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.